• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 全球风湿病联盟:评估针对最佳实践的国际注册快速设计和实施。

The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice.

机构信息

Division of Rheumatology, University of Washington, Seattle, WA.

Rheumatologist, Crystal Run Health, Middletown, NY, USA.

出版信息

Rheumatology (Oxford). 2021 Jan 5;60(1):353-358. doi: 10.1093/rheumatology/keaa483.

DOI:10.1093/rheumatology/keaa483
PMID:32789449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454885/
Abstract

OBJECTIVES

As the coronavirus disease 2019 pandemic developed there was a paucity of data relevant to people living with rheumatic disease. This led to the development of a global, online registry to meet these information needs. This manuscript provides a detailed description of the coronavirus disease 2019 Global Rheumatology Alliance registry development, governance structure, and data collection, and insights into new ways of rapidly establishing global research collaborations to meet urgent research needs.

METHODS

We use previously published recommendations for best practices for registry implementation and describe the development of the Global Rheumatology Alliance registry in terms of these steps. We identify how and why these steps were adapted or modified. In Phase 1 of registry development, the purpose of the registry and key stakeholders were identified on online platforms, Twitter and Slack. Phase 2 consisted of protocol and data collection form development, team building and the implementation of governance and policies.

RESULTS

All key steps of the registry development best practices framework were met, though with the need for adaptation in some areas. Outputs of the registry, two months after initial conception, are also described.

CONCLUSION

The Global Rheumatology Alliance registry will provide highly useful, timely data to inform clinical care and identify further research priorities for people with rheumatic disease with coronavirus disease 2019. The formation of an international team, easily able to function in online environments and resulting in rapid deployment of a registry is a model that can be adapted for other disease states and future global collaborations.

摘要

目的

随着 2019 年冠状病毒病(COVID-19)大流行的发展,针对风湿病患者的相关数据非常匮乏。这导致了一个全球性的在线注册系统的开发,以满足这些信息需求。本文详细介绍了 2019 年冠状病毒病全球风湿病联盟(Global Rheumatology Alliance,GRA)注册系统的开发、治理结构和数据收集,并深入了解了迅速建立全球研究合作关系以满足紧迫研究需求的新方法。

方法

我们使用先前发表的关于注册实施最佳实践的建议,并根据这些步骤描述 GRA 注册系统的开发。我们确定了这些步骤是如何以及为何进行了调整或修改。在注册开发的第一阶段,通过在线平台、Twitter 和 Slack 确定了注册的目的和主要利益相关者。第二阶段包括协议和数据收集表的开发、团队组建以及治理和政策的实施。

结果

满足了注册开发最佳实践框架的所有关键步骤,但在某些方面需要进行调整。还描述了注册系统在初步构想两个月后的产出。

结论

GRA 注册系统将为患有 COVID-19 的风湿病患者提供非常有用和及时的数据,以指导临床护理并确定进一步的研究重点。国际团队的组建,能够轻松地在在线环境中运作,并迅速部署注册系统,这是一种可以应用于其他疾病状态和未来全球合作的模式。

相似文献

1
The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice.COVID-19 全球风湿病联盟:评估针对最佳实践的国际注册快速设计和实施。
Rheumatology (Oxford). 2021 Jan 5;60(1):353-358. doi: 10.1093/rheumatology/keaa483.
2
Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance.全球研究合作在大流行中的挑战与机遇:COVID-19 全球风湿病联盟。
Curr Opin Rheumatol. 2021 Mar 1;33(2):111-116. doi: 10.1097/BOR.0000000000000783.
3
#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic.Covid4Rheum:COVID-19 大流行时期的推特分析研究。
Rheumatol Int. 2020 Dec;40(12):2031-2037. doi: 10.1007/s00296-020-04710-5. Epub 2020 Sep 29.
4
Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.种族和民族与风湿性疾病 COVID-19 结局的关联:来自 COVID-19 全球风湿病联盟医师注册处的数据。
Arthritis Rheumatol. 2021 Mar;73(3):374-380. doi: 10.1002/art.41567. Epub 2021 Feb 2.
5
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.日本 COVID-19 合并基础风湿性疾病患者的临床特征:一项使用 COVID-19 全球风湿病联盟医生报告登记处的多中心观察性研究的数据。
Clin Rheumatol. 2022 Dec;41(12):3661-3673. doi: 10.1007/s10067-022-06305-w. Epub 2022 Aug 16.
6
Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.关于“风湿性疾病患者中与COVID-19相关死亡的因素:COVID-19全球风湿病联盟医生报告登记处的结果”的通信
Ann Rheum Dis. 2023 May;82(5):e115. doi: 10.1136/annrheumdis-2021-220099. Epub 2021 Mar 1.
7
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.抗击新冠疫情需要您的帮助:请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2021 Dec;24(12):1547. doi: 10.1111/1756-185X.14192.
8
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.抗击新冠疫情需要您的帮助:请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2021 Jun;24(6):860. doi: 10.1111/1756-185X.14117.
9
COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.科威特风湿性疾病患者的 COVID-19 结局:来自 COVID-19 全球风湿病联盟(C19-GRA)医生登记处的数据。
Int J Rheum Dis. 2022 Jul;25(7):743-754. doi: 10.1111/1756-185X.14332. Epub 2022 May 11.
10
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance registry.抗击新冠疫情需要您的帮助:请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2021 Feb;24(2):286. doi: 10.1111/1756-185X.14073.

引用本文的文献

1
COVID-19 vaccine booster uptake and effectiveness among persons with systemic autoimmune and rheumatic diseases.2019冠状病毒病疫苗加强针在患有系统性自身免疫性和风湿性疾病人群中的接种情况及有效性
J Rheumatol. 2025 Aug 1. doi: 10.3899/jrheum.2025-0535.
2
Social media in advancing equity and collaboration in rheumatology: the CORDIALITY review.社交媒体促进风湿病学的公平性与合作:CORDIALITY综述
RMD Open. 2025 Mar 27;11(1):e005490. doi: 10.1136/rmdopen-2025-005490.
3
Social Media for Research Discourse, Dissemination, and Collaboration in Rheumatology.用于风湿病学研究话语、传播和协作的社交媒体。
Rheumatol Immunol Res. 2022 Dec 31;3(4):169-179. doi: 10.2478/rir-2022-0031. eCollection 2022 Dec.
4
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.银屑病、银屑病关节炎和中轴型脊柱关节炎患者 COVID-19 结局不良的相关特征:COVID-19 PsoProtect 和全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2023 May;82(5):698-709. doi: 10.1136/ard-2022-223499. Epub 2023 Feb 14.
5
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey.ASAS 成员的社交媒体使用情况:一项基于网络的调查结果。
J Med Internet Res. 2023 Jan 10;25:e39155. doi: 10.2196/39155.
6
Risk of Severe SARS-CoV-2 Infection in Patients with Autoimmune Rheumatic Diseases in Qatar: A Cohort Matched Study.卡塔尔自身免疫性风湿病患者感染重症严重急性呼吸综合征冠状病毒2的风险:一项队列匹配研究。
Qatar Med J. 2022 Jun 20;2022(3):24. doi: 10.5339/qmj.2022.24. eCollection 2022.
7
The Pediatric COVID-19 Registry in Kuwait: Methodology and Results of Pilot Phase.科威特儿科 COVID-19 登记处:试点阶段的方法和结果。
Med Princ Pract. 2022;31(5):471-479. doi: 10.1159/000524756. Epub 2022 May 20.
8
COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.科威特风湿性疾病患者的 COVID-19 结局:来自 COVID-19 全球风湿病联盟(C19-GRA)医生登记处的数据。
Int J Rheum Dis. 2022 Jul;25(7):743-754. doi: 10.1111/1756-185X.14332. Epub 2022 May 11.
9
The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey.2019冠状病毒病对风湿病学培训的影响——来自2019冠状病毒病全球风湿病联盟学员调查的结果
Rheumatol Adv Pract. 2022 Feb 21;6(1):rkac001. doi: 10.1093/rap/rkac001. eCollection 2022.
10
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.接种疫苗的风湿病患者中出现的SARS-CoV-2突破性感染:来自COVID-19全球风湿病联盟提供者登记处的结果。
RMD Open. 2022 Apr;8(1). doi: 10.1136/rmdopen-2021-002187.

本文引用的文献

1
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者因 COVID-19 住院的相关特征:来自 COVID-19 全球风湿病联盟医生报告登记处的数据。
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.
2
The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness.病毒感染与呼吸道疾病通用研究(VIRUS):2019年冠状病毒相关危重症国际登记处。
Crit Care Explor. 2020 Apr 29;2(4):e0113. doi: 10.1097/CCE.0000000000000113. eCollection 2020 Apr.
3
Capturing Patient-Reported Outcomes During the COVID-19 Pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.在2019冠状病毒病大流行期间收集患者报告的结果:2019冠状病毒病全球风湿病联盟患者体验调查的开发
Arthritis Care Res (Hoboken). 2020 Jul;72(7):871-873. doi: 10.1002/acr.24257.
4
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients.免疫抑制性炎症性肠病患者感染新型冠状病毒的风险
Crohns Colitis 360. 2020 Apr;2(2):otaa026. doi: 10.1093/crocol/otaa026. Epub 2020 Apr 16.
5
The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.风湿病学界对COVID-19大流行的应对:COVID-19全球风湿病联盟的成立。
Rheumatology (Oxford). 2020 Jun 1;59(6):1204-1206. doi: 10.1093/rheumatology/keaa191.
6
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.风湿性疾病与2019冠状病毒病:来自2019冠状病毒病全球风湿病联盟医疗服务提供者登记处的初步数据。
Lancet Rheumatol. 2020 May;2(5):e250-e253. doi: 10.1016/S2665-9913(20)30095-3. Epub 2020 Apr 16.
7
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.COVID-19 全球风湿病联盟:大流行期间的数据收集。
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
8
Covid-19 - Navigating the Uncharted.新冠疫情——探索未知领域。
N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.
9
Design and Implementation of a Depression Registry for Primary Care.基层医疗抑郁症登记系统的设计与实现
Am J Med Qual. 2019 Jan/Feb;34(1):59-66. doi: 10.1177/1062860618787056. Epub 2018 Jul 16.
10
CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.慢性肾脏病。昆士兰:在澳大利亚昆士兰建立慢性肾脏病(CKD)登记处。
BMC Nephrol. 2017 Jun 7;18(1):189. doi: 10.1186/s12882-017-0607-5.